and is aetiologically associated with Burkitt's lymphoma (Epstein & Achong, 1979) and nasopharyngeal carcinoma (Epstein, 1978) . In most individuals infection occurs subclinically during childhood (Evans et al., 1968) and leads to the production of antibodies to virus-determined antigens which thereafter persist for life (Hewetson et al., 1973) . Following either IM or sub-clinical infection EB virus persists in the body, and can be found in saliva (Golden et al., 1973) and in lymphoid tissue (Nilsson et al., 1971) . This persistent infection with EBV is probably, at least in part, controlled by EBV-specific memory T cells which have been demonstrated in the peripheral blood of seropositive individuals (Moss et al., 1978) . These T cells are activated in cultures of EB virusinfected peripheral blood mononuclear cells to produce cytotoxic cells which then cause regression of proliferating foci of the EB virus-infected B cells within the culture (Rickinson et al., 1979) in an HLA-restricted manner (Rickinson et al., 1980) .
Epstein-Barr virus (EBV) is a B lymphotrophic human herpes virus which is the causative agent of Infectious Mononucleosis (IM)
and is aetiologically associated with Burkitt's lymphoma (Epstein & Achong, 1979) and nasopharyngeal carcinoma (Epstein, 1978) . In most individuals infection occurs subclinically during childhood (Evans et al., 1968) and leads to the production of antibodies to virus-determined antigens which thereafter persist for life (Hewetson et al., 1973) . Following either IM or sub-clinical infection EB virus persists in the body, and can be found in saliva (Golden et al., 1973) and in lymphoid tissue (Nilsson et al., 1971) . This persistent infection with EBV is probably, at least in part, controlled by EBV-specific memory T cells which have been demonstrated in the peripheral blood of seropositive individuals (Moss et al., 1978) .
These T cells are activated in cultures of EB virusinfected peripheral blood mononuclear cells to produce cytotoxic cells which then cause regression of proliferating foci of the EB virus-infected B cells within the culture (Rickinson et al., 1979) in an HLA-restricted manner (Rickinson et al., 1980) .
In the present study we have used the fluorescence activated cell sorter (FACS) to separate peripheral blood cells stained with monoclonal antibodies into subsets with specific activities. These subsets have then been assayed for their capacity to cause regression of autologous EBV-infected B cell targets. Correspondence: D.H. Crawford Received 29 November 1982; accepted 12 February 1983. Materials and methods Medium RPMI 1640 medium containing 2mM glutamine, 100 IU penicillin and 100 IU streptomycin was used throughout. 5 mM HEPES buffer and 2% calf serum were added for all cell preparation procedures, and 20% v/v foetal calf serum (FCS) was added for all culture procedures.
Donors
Normal healthy adults who were seropositive for antibodies to EB virus were selected as leucocyte donors.
Cell preparation Whole blood was diluted with an equal volume of medium and centrifuged on a Ficoll-hypaque gradient. The peripheral blood mononuclear cells (PBMC) were harvested from the interface band and washed twice in medium. E rosettes were formed using AET-treated sheep red cells by the method of Kaplan & Clark (1974) and the E rosette-positive population (E+) was separated from the E rosette-negative population (E-) on a percoll gradient (Callard & Smith, 1981) . The E-cells were harvested from the interface band and the E+ cells were recovered from the pellet by lysis of the red cells with 0.83% ammonium chloride. Both cell populations were washed twice in medium before use.
(C) The Macmillan Press Ltd., 1983 EBV infection Pellets of cells were infected with EBV by resuspending them at a concentration of 10iml-' in the supernatant medium of B95-8 cell line (Miller et al., 1972) The cells to be stained were resuspended at a concentration of 107/ml-1 in the unconjugated antibody preparations which had been filtered through a 0.22p filter. They were incubated at 4°C for 30 min washed twice in medium and then resuspended in the diluted, filtered Sh anti MIg FITC conjugated antibody at a concentration of 107 cells ml-1 and incubated for a further 30min at 4°C. After two washes the cells were resuspended in medium at 5 x 106/ml-1 ready for analysis on the FACS.
FACS analysis
The analysis and separation of FITC-labelled cells were performed on a FACS-TI or a FACS IV (Becton Dickinson FACS Systems, Mountain View, California, U.S.A.). Relative light scatter and fluorescence intensities were displayed as a 2-dimensional dot plot. The standard conditions for analysis and sorting were laser power-300 MW, 488 nm, photomultiplier tube voltage 850 V with light scatter and fluorescence gain of 16. The windows for separating the positively and negatively stained cells were set using identical criteria to Callard et al., 1982. Cell culture Unless otherwise stated cells were cultured in 0.2 ml aliquots in microtitre wells at a concentration of 2 x 106/ml -'. The cultures were incubated at 37°C in a humidified atmosphere containing 5% CO2 and fed weekly by replacement of half the medium without disturbing the cell layer. They were examined weekly under an inverted microscope for the development of proliferating foci and for the onset of regression. The incidence of regression or transformation in each set of cultures was scored by eye after one month.
Results
Monoclonal antibodies Leu 2a, Leu 3a and H25/H366 have each been used to stain PBMC in 2 experiments. The percentage of PBMC which stained with each antibody are shown in Table I .
Leu 2a stained 32% and 26% of PBM whereas Leu 3a stained 65% and 62%. H25/H366 stained 20% of PBM in both experiments.
The E+ cells were separated into positively and negatively staining populations using the FACS. Unseparated PBM, and where possible an unseparated, stained E + cell population were retained. Each population, as well as unseparated, stained E + cells, was washed, resuspended at 3 x 10 ml-1 and added in 0.1 ml aliquots to the 0.1 ml cultures of EBV-infected E -cells. Thus, each well contained 4 x 105 cells with an E +:E-ratio of 3:1. To some wells containing the E-cells 0.1 ml of medium alone was added.
In all the experiments control cultures containing EBV-infected whole PBMC (at 4 x i05 well) and in some experiments cultures containing EBV-infected E-cells with stained, unseparated E+ cells (recombined in a 1:3 ratio, 10:3 x 105 cells/well) were set up and all showed the expected regression after a one-month culture period (Table I) . In all experiments the EBV-infected E-cell populations, when cultured alone (105 cells/well) showed no evidence of regression (Table I) . When E+ cells were separated into Leu 2a+ and Leu 2a-populations and these cells were added to EBV-infected E-cells in a 3:1 ratio (3 x 105:105 cells/well) all those cultures receiving the Leu 2a+ cells in both experiments showed regression (6/6 and 5/5 cultures) after a one-month culture period, whereas out of all those receiving the Leu 2a-cells in both experiments only one culture well showed regression (0/10 and 1/9 cultures). EBV-transformed cell lines were obtained from these cultures, however the proliferating foci of cells appeared later and grew slower than those in cultures containing E-cells alone.
When experiments of exactly the same design were carried out using E+ cells stained with Leu 3a those cultures of EBV-infected B cells which received the Leu 3a+ cells showed little evidence of regression after a one-month culture period (0 out of 10 and 2 out of 10) although the transformed foci appeared later than those in the E-alone culture wells. Conversely, when Leu 3a-cells were added to cultures of EBV-infected E-cells all cultures showed regression (4/4 and 3/3) ( Table I) .
In experiments using H25 and H366 antibodies whole PBMC were stained with antibody and separated into positive and negative fractions on the FACS. Following this procedure the H25/H366 negative population was further separated into E+ and E-fractions. The H2S/H366 positive fraction and the H25/H366 negative E+ fraction were then recombined with EBV-infected E-cells for culture. When H25/H366 positive cells were cultured with EBV-infected E-cells no evidence of regression was apparent in 2 identical experiments after a onemonth culture period. However, the proliferating foci of cells appeared later in these cultures than in those receiving EBV-infected E-cells alone. Regression occurred in all culture wells containing the H25/H366 negative E+ fractions (Table I) (Table II) . In experiments using the RFB-HLA-DR antibody PBMC were infected with EBV and cultured at 1-2x 106ml-1 in 2ml costar wells. In each experiment medium containing 1 yg ml-1 of cyclosporin A (CSA) was added to 1 culture well. After 0 and 7 days in culture the cells were E rosetted, and the E + fractions were stained with RFB-HLA-DR. The E+ cells from cultures containing medium with and without CSA were analysed on the FACS.
The freshly isolated cells (Day 0) contained 2, < 1 and 1% of E+ cells expressing Ta antigens whereas in the respective 7 day non-CSA-containing cultures 24, 18 and 38% of E+ cells were Ia'. In 7 day CSA-containing cultures 6, 8 and 10% of cells expressed Ta (Table III) . Those cells which had been cultured without CSA were separated into positively and negatively staining fractions. Both fractions were cultured in 0.1 ml volumes at a concentration of 3 x 106 ml -Iwith 0.1 ml of freshly prepared EBV-infected, autologous E-cells at 1066ml-'. Cultures containing both the Ia' and the Ta-E+ cells showed regression (Table I) although the regression phenomenon was apparent earlier in those cultures receiving the Ta+ E+ cells. (Rickinson et al., 1979) . However, other factors may also influence the final outcome of regression or transformation of B cells after a one-month culture period; in particular interferon production by the cultured cells (ThorleyLawson, 1981) or NK cell activity may be important. For this reason we decided to further investigate the cell types involved in the generation of regression.
In our experiments regression regularly occurred in cultures of EBV-infected PBMC seeded at high initial cell concentrations but was completely absent when EBV-infected E-cells were cultured alone (Table I) . These results confirm the findings of other workers (Rickinson et al., 1979) , and indicate that E+ cells are necessary in a culture for regression to occur. When the FACS was used to separate Leu 2a+ (suppressor/cytotoxic)+ from Leu 2a-cells regression only regularly occurred in cultures receiving the Leu 2a+ cells. Conversely when Leu 3a (helper/inducer) antibody was used in identical experiments only the cultures receiving Leu 3a-cells regularly showed regression (Table I) . When the regression activity in Leu 2a+ and total E+ cell fractions was titrated on fixed numbers of EBVinfected E-cells, lower numbers of Leu 2a+ cells could be used to cause complete regression revealing an enrichment of effector cells in this cell fraction (Table II) .
These clear-cut results indicate that the cytotoxic activity resides within the Leu 2a+, Leu 3a-T cell fraction, and suggest that, in this system, collaborative T-T cell interactions between helper/inducer and suppressor/cytotoxic T cell subsets as defined by Leu 2a and 3a play a minor role in the generation of the cytotoxic cells. We have similarly found little evidence for interaction between these two subsets in the generation of help or suppression for in vitro antibody responses to influenza virus (Callard et al., 1982) . However, it is still possible that there may be further heterogeneity within both subsets, and evidence for this has been reported in response to pokeweed mitogen (Thomas et al., 1981) . Our findings may reflect the fact that these cytotoxic T cells are constantly activated in vivo by the low numbers of EBV-carrying B lymphocytes known to be present in the circulation of all seropositive individuals (Nilsson et al., 1971) and that T-T interactions are important only in the generation of primary responses. Since FCS has been shown to selectively induce the generation of cytotoxic T cells with a preferential lysis for autologous cell lines (Misko et al., 1982) we carried out one further separation experiment using the Leu 2a antibody in which all the cell cultures were set up in medium containing 20% AB serum from a seronegative donor in place of FCS. In this experiment all the regression activity again occurred in the cultures receiving Leu 2a+ cells, and thus an active role for FCS in the generation of cytotoxic T cells in our experiments was excluded.
Other workers have shown that the number of cells with suppressor/cytotoxic phenotype (OKT8+) is increased in cultures of PBMC after challenge with the autologous EBV genome-containing B cell lines, and that the cytotoxic response was abrogated after removal of the OKT8 + population by complement-mediated lysis (Tsoukas et al., 1981) . In the experiments presented here the use of the FACS allowed the preservation of both positively-and negatively-staining fractions which could then be tested in parallel in the regression assay.
In our experiments using Leu 2a and Leu 3a monoclonal antibodies it was noted that although actively proliferating B cell lines were present after a one-month period in those cultures receiving the helper/inducer (Leu 2a-, Leu 3a+) cells, the proliferating foci of EBV-transformed B cells appeared later and initially grew at a slower rate than those in cultures containing EBV-infected Ecells alone. We further investigated this observation by using the FACS to enrich NK cells (H25/H266+) from PBMC. When these cells were cultured with EBV-infected E-cells no regression was seen after a one-month culture period; all the cytotoxic activity was found to reside in the H25/H366-E+ cell fraction (Table I) . Once again some delay in the outgrowth of the proliferating foci of B cells was noted in the cultures containing the enriched NK cells when they were compared with the EBVinfected E-cells early in the culture period. This may have been due to NK cells acting against EBV-infected targets early in the culture period, or alternatively this early delay in outgrowth of EBVinfected B cells may be due to the production of interferon within the culture. This phenomenon has been described previously (Thorley-Lawson, 1981) and was not investigated further in our experiments since it did not alter the final outcome of the cultures from normal individuals when scored for regression after one month. However, in certain pathological situations enhancement or abrogation of these subsidiary mechanisms may affect the regression assay (Pereira et al., 1982) .
HLA-DR antigens (Ia) are known to be expressed on all human B lymphocytes, and have also been described on a subset of T lymphocytes which appear to be activated (Evans et al., 1978) . In this work we have studied the generation of Ia+ T cells in cultures one week after EBV-infection of PBMC when cytotoxic T cells are known to be present (Moss et al., 1981) . We have compared this with the generation of Ta + cells in identical cultures containing CSA-a drug which is known to prevent the generation of cytotoxic T cells and the regression phenomenon (Bird et al., 1981) . The levels of Ia+ T cells in fresh PBMC is low (0-2%), and this percentage rises after EBV-infection and 7 days in culture (18-38%). The addition of CSA to the culture medium can be seen to inhibit the expression of Ta on cultured T cells (Table III) a finding which has been reported using CSA in autologous lymphocyte systems (Palacios & Moller, 1981) . This finding suggests that the phenotype of the actively cytotoxic cells is Ia' E+. FACS separation of these Ta+ E+ cells from the Ia -E+ population shows that both fractions contain cells which are capable of causing regression when cultured with EBV-infected E-cells (Table I ). Too few Ta+ E+ cells were collected to perform a titration experiment with these fractions, however enrichment of the cytotoxic cells in the la' E+ fraction was suggested by a more rapid onset of regression in cultures receiving these cells. Although these cell culture experiments show that both the Ta+ and Ta-E+ cells are capable of generating the cytotoxic T cells which cause regression, the possibility still remains that during the culture period the Ta-cells become Ta+ before becoming actively cytotoxic. This could be resolved using the chromium release assay to assess the cytotoxicity of the Ia' and Ia-E+ fractions immediately after separation.
In conclusion, we have shown that in cultures of PBMC from normal individuals the regression of proliferating foci of EBV-infected B cells observed after one month is caused by Leu 2a+ T cells which are mostly Ta'.
